Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Stock Elyse
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-14
Sale
2021-12-16
9:04 pm
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
28,858 $105.37 $3,040,889 54,649
(Indirect
Direct)
View
2020-06-12
Sale
2020-06-12
9:51 pm
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
36,966 $64.83 $2,396,502 73,427
(Indirect
Direct)
View
2019-10-18
Sale
2019-10-25
8:39 pm
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
17,700 $45.07 $797,750 18,500
(Direct)
View
2019-10-15
Sale
2019-10-17
6:29 pm
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
800 $45.01 $36,008 36,200
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-10
Exercise
2022-01-12
9:10 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
937 $0 17,402
(Indirect)
View
2022-01-06
Option Award
2022-01-07
9:17 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
17,000 $0 81,277
(Direct)
View
2022-01-06
Tax Withholding
2022-01-07
9:17 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
1,838 $123.86 81,277
(Direct)
View
2022-01-06
Tax Withholding
2022-01-07
9:17 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
1,539 $128.87 81,277
(Direct)
View
2022-01-06
Exercise
2022-01-07
9:17 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
35,250 $0 81,277
(Direct)
View
2021-12-14
Exercise
2021-12-16
9:04 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
10,358 $20.79 54,649
(Direct)
View
2021-12-14
Exercise
2021-12-16
9:04 pm
N/A
2027-12-06
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
28,858 $0 54,649
(Direct)
View
2021-12-14
Exercise
2021-12-16
9:04 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
18,500 $10.82 54,649
(Direct)
View
2021-11-25
Exercise
2021-11-26
4:33 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
3,375 $0 13,029
(Direct)
View
2021-11-25
Tax Withholding
2021-11-26
4:33 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
1,599 $115.55 13,029
(Direct)
View
2021-01-06
Option Award
2021-01-08
8:49 pm
N/A
2031-01-06
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
50,000 $0 72,878
(Direct)
View
2021-01-06
Tax Withholding
2021-01-08
8:49 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
1,747 $83.38 72,878
(Direct)
View
2021-01-06
Exercise
2021-01-08
8:49 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
5,000 $0 72,878
(Direct)
View
2020-11-25
Exercise
2020-11-27
9:48 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
3,375 $0 11,375
(Direct)
View
2020-11-25
Tax Withholding
2020-11-27
9:48 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
1,531 $90.14 11,375
(Direct)
View
2020-06-12
Exercise
2020-06-12
9:51 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
20,716 $20.79 73,427
(Direct)
View
2020-06-12
Exercise
2020-06-12
9:51 pm
N/A
2028-11-20
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
36,966 $0 73,427
(Direct)
View
2020-06-12
Exercise
2020-06-12
9:51 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
16,250 $32.42 73,427
(Direct)
View
2020-01-08
Exercise
2020-01-10
7:46 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
937 $55.91 9,344
(Indirect)
View
2020-01-08
Exercise
2020-01-10
7:46 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
4,687 $0 9,344
(Indirect)
View
2019-12-18
Option Award
2019-12-20
9:41 pm
N/A
2029-12-18
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
15,000 $0 26,969
(Indirect)
View
2019-12-18
Exercise
2019-12-20
9:41 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
3,375 $0 26,969
(Direct)
View
2019-12-18
Tax Withholding
2019-12-20
9:41 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
1,531 $52.13 26,969
(Direct)
View
2019-11-25
Option Award
2019-11-27
9:30 pm
N/A
2029-11-24
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
38,500 $0 38,500
(Direct)
View
2019-10-18
Exercise
2019-10-25
8:39 pm
N/A
2027-04-05
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
17,700 $0 18,500
(Direct)
View
2019-10-18
Exercise
2019-10-25
8:39 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
17,700 $10.82 18,500
(Direct)
View
2019-10-15
Exercise
2019-10-17
6:29 pm
N/A
2027-04-05
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
800 $0 36,200
(Direct)
View
2019-10-15
Exercise
2019-10-17
6:29 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
800 $10.82 36,200
(Direct)
View
2019-09-17
Option Award
2019-09-19
9:05 pm
N/A
2029-09-16
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
11,000 $0 11,000
(Indirect)
View
2019-08-08
Ownership
2019-08-19
6:41 pm
N/A
2027-04-05
Biohaven Pharmaceutical Holding Co Ltd. BHVN Stock Elyse
Chief Medical Officer
0 $0 160,612
(Direct)
View